These 10 Firms Led This Week’s Rally

8. Royalty Pharma Plc (NASDAQ:RPRX)

Royalty Pharma (RPRX) saw its share price increase by 14.26 percent to end at $29.49 apiece versus the $25.81 posted the week prior, following news that it was set to acquire its external manager RP Management, as it seeks to simplify its corporate structure.

On a financial basis, the acquisition plan was expected to generate cash savings for the company of up to $100 million in 2026, more than $175 in 2030, and drive cumulative savings worth at least $1.6 billion over ten years.

Royalty Pharma (RPRX) said its decision followed investors’ feedback that the current structure made it difficult to invest in the healthcare firm, and shifting to internal management could enhance the company’s valuation over time.